S018 Psoriasis
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Join this exciting psoriasis symposium, where the learners will gain high-yield, practical information on the management of psoriasis using topical, oral, and biologic therapies. We will describe and differentiate the mechanisms of action, efficacy, and safety among FDA-approved and emerging therapies to treat psoriasis. We will also discuss the management of difficult-to-treat subtypes of psoriasis such as nail psoriasis. Additionally, learners will hear updates on biomarker development in psoriasis and management of psoriatic arthritis. Finally, the symposium will have two spirited debates: (1) whether non-steroidal topical medications replace topical steroids in the treatment of psoriasis, and (2) oral versus biologic therapy for the treatment of mild to moderate psoriasis. Come to be informed, inspired, and entertained.
LEARNING OBJECTIVES
Differentiate the mechanisms of action of psoriasis therapies and describe novel insights in biomarkers for psoriasis and psoriatic arthritis and their clinical applications.
Discuss the practical use of topical, oral, and biologic therapies for the management of psoriasis and psoriatic arthritis.
Debate (1) whether non-steroidal topical medications will replace topical steroids in the treatment of psoriasis (2) oral versus biologic therapy for the treatment of mild-to-moderate psoriasis.
SCHEDULE
9:00 PM
Welcome and Introduction
April W. Armstrong, MD, MPH, FAAD
9:05 PM
Novel Insights in Biomarkers for Psoriasis and Psoriatic Arthritis and Their Clinical Applications
Andrew Blauvelt, MD, FAAD
9:20 PM
Evolving Landscape of Oral Therapies for Psoriasis
April W. Armstrong, MD, MPH, FAAD
9:35 PM
Nail psoriasis or onychomycosis? Pearls on diagnosis and management of psoriatic nail disease
Boni E. Elewski, MD, FAAD
9:50 PM
Debate #1: Will non-steroidal topical medications replace topical steroids in the treatment of psoriasis?
Kenneth B. Gordon, MD, FAAD, Bruce Elliot Strober, MD, PhD, FAAD
10:25 PM
Mastering the Use of IL-23 inhibitors in psoriasis and psoriatic arthritis
Joel M. Gelfand, MD, MSCE, FAAD
10:40 PM
Practical considerations in Using IL-17 inhibitors for psoriasis and psoriatic arthritis
Joseph Merola, MD, MSc, FAAD
10:55 PM
Doppelgängers or Twins? What to know about biosimilars
Mark Lebwohl, MD, FAAD
11:10 PM
Debate #2: Oral versus biologic therapy for the treatment of mild to moderate psoriasis
Kristina Patrice Callis-Duffin, MD, FAAD, Wilson Liao, MD, FAAD
11:45 PM
Question and Answer
SPEAKERS
April W. Armstrong, MD, MPH, FAAD
Andrew Blauvelt, MD, FAAD
Kristina Patrice Callis-Duffin, MD, FAAD
Boni E. Elewski, MD, FAAD
Joel M. Gelfand, MD, MSCE, FAAD
Kenneth B. Gordon, MD, FAAD
Mark Lebwohl, MD, FAAD
Wilson Liao, MD, FAAD
Joseph Merola, MD, MSc, FAAD
Bruce Elliot Strober, MD, PhD, FAAD
HANDOUTS
SPEAKER DISCLOSURES
April W. Armstrong, MD, MPH, FAAD
AbbVie – Advisory Board(Honoraria); Amgen – Advisory Board(Honoraria); Arcutis Biotherapeutics – Consultant(Honoraria); Boehringer Ingelheim – Data Safety Monitoring Board(Honoraria); Bristol-Myers Squibb – Investigator(Grants/Research Funding), Speaker(Honoraria); Dermavant Sciences – Consultant(Honoraria), Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Galderma USA – Advisory Board(Honoraria); Incyte – Investigator(Grants/Research Funding); Incyte Corporation – Advisory Board(Honoraria); Janssen Biotech – Speaker(Honoraria); Janssen-Ortho Inc. – Investigator(Grants/Research Funding); Leo Pharma Inc – Consultant(Honoraria), Investigator(Grants/Research Funding); Meiji – Investigator(Grants/Research Funding); Novartis – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Ortho Dermatologics – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Regeneron – Advisory Board(Honoraria); Sanofi Genzyme – Consultant(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Andrew Blauvelt, MD, FAAD
AbbVie – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Fees); Almirall – Advisory Board(Honoraria), Consultant(Honoraria); Alumis – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Fees); Amgen – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Fees); AnaptysBio – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Fees); Apogee Therapeutics – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Arcutis, Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Fees); Boehringer Ingelheim – Advisory Board(Honoraria), Consultant(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding); Dermavant Sciences – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Fees); Eli Lilly and Company – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Fees), Speaker(Honoraria); Galderma Laboratories, L.P. – Advisory Board(Honoraria), Consultant(Honoraria); Galderma USA – Investigator(Fees); GlaxoSmithKline Immunology – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Incyte Corporation – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Fees); Janssen-Ortho Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Fees); Leo Pharma Inc – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Fees); Lipidio Pharmaceuticals – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Stockholder Private Company(Stock); Merck – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria), Consultant(Honoraria); Oruka Therapeutics – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Stockholder Public Company(Stock); Pfizer Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Fees); Regeneron – Advisory Board(Honoraria), Consultant(Honoraria); Sanofi – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Fees); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria), Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Fees); UCB – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Fees), Speaker(Honoraria); Union Therapeutics – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria);
Kristina Patrice Callis-Duffin, MD, FAAD
AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Amgen – Advisory Board(Honoraria), Consultant(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees); Celgene Corporation – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant(Honoraria), Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Novartis – Consultant(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding);
Boni E. Elewski, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); AnaptysBio – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria), Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); Foundation for Research & Education of Dermatology – Advisory Board(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); InflaRx GmbH – Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Consultant (1099 relationship)(Honoraria); Janssen-Ortho Inc. – Investigator(Grants/Research Funding); LEO Laboratories Ltd (LEO Pharma) – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Novartis Pharmaceuticals Corp. – Consultant(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Investigator(Grants/Research Funding); UCB – Consultant(Honoraria), Investigator(Grants/Research Funding); Valeant Pharmaceuticals International – Consultant(Honoraria); Valeant Pharmaceuticals North America LLC – Investigator(Grants/Research Funding); Vanda Pharmaceuticals Inc. – Investigator(Grants/Research Funding); Verrica Pharmaceuticals Inc – Advisory Board(Honoraria);
Joel M. Gelfand, MD, MSCE, FAAD
AbbVie – Consultant(Fees); Abcentra – Consultant(Fees); Amgen – Investigator(Grants/Research Funding); Artax Biopharma – Data Safety Monitoring Board(Fees); BMS – Consultant(Fees); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); CellDex – Data Safety Monitoring Board(Fees); Daavlin Company – Other(Equipment); FIDE – Consultant(Fees); GlaxoSmithKline – Consultant(Honoraria); Happify – Consultant(Fees); Healio – Other(Fees); Imagine – Data Safety Monitoring Board(Fees); Inmagene Biopharmaceuticals – Data Safety Monitoring Board(Fees); Janssen Pharmaceuticals, Inc – Consultant(Honoraria), Investigator(Grants/Research Funding); Leo Pharma Inc – Consultant(Fees); Mindera – Consultant(Fees); Moonlake – Data Safety Monitoring Board(Fees); National Psoriasis Foundation – Investigator(Grants/Research Funding); Neumentum, Inc. – Consultant(Fees); Neuroderm LTD – Other(Fees); Novartis Pharmaceuticals Corp. – Consultant(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); UCB – Other(Fees); Veolia North America – Consultant(Fees);
Kenneth B. Gordon, MD, FAAD
AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding); Almirall – Consultant(Honoraria); Amgen – Consultant(Honoraria); Arcutis, Inc. – Consultant(Honoraria); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria); Dermavant Sciences – Consultant(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Incyte Corporation – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Leo Pharma Inc – Consultant(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria); Othro Dermatologics – Consultant(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Protagonist Therapeutics – Consultant (1099 relationship)(Honoraria); Sanofi Genzyme – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); UCB – Consultant(Honoraria);
Mark Lebwohl, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Almirall – Consultant(Honoraria); AltruBio Inc. – Consultant(Honoraria); Apogee Therapeutics – Consultant(Honoraria); Arcutis, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); AstraZeneca – Consultant (1099 relationship)(Honoraria); Atomwise – Consultant(Honoraria); Avotres, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria); Cara Therapeutics – Investigator(Grants/Research Funding); Castle Biosciences, Inc – Consultant(Honoraria); Celltrion – Consultant(Honoraria); Clexio Biosciences, Ltd – Investigator(Grants/Research Funding); CoreEvitas, LLC – Consultant(Honoraria); Dermavant Sciences – Consultant(Honoraria), Investigator(Grants/Research Funding); Dermsquared – Consultant (1099 relationship)(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Evommune, Inc. – Consultant(Honoraria); Facilitation of International Dermatology Education – Consultant(Honoraria); Forte Biosciences – Consultant(Honoraria); Galderma – Consultant(Honoraria); Genentech, Inc. – Consultant(Honoraria); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding); Inozyme Pharma – Investigator(Grants/Research Funding); Janssen Research & Development, LLC – Investigator(Grants/Research Funding); Leo Pharma A/S – Consultant(Honoraria); Meiji Seika Pharma Co., Ltd – Consultant(Honoraria); Mindera – Consultant(Honoraria); New York College of Podiatric Medicine – Speaker/Faculty Education(Honoraria); Ortho Dermatologics – Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Sanofi/Regeneron – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Seanergy Maritime Holdings Corp. – Consultant(Honoraria); Strata Skin Sciences – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); Trevi Therapeutics – Consultant(Honoraria); UCB – Investigator(Grants/Research Funding); Verrica Pharmaceuticals Inc – Consultant(Honoraria);
Wilson Liao, MD, FAAD
Amgen – Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Investigator(Grants/Research Funding); Leo Pharma Inc – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Regeneron – Investigator(Grants/Research Funding);
Joseph Merola, MD, MSc, FAAD
AbbVie – Consultant(Honoraria); Amgen – Advisory Board(Honoraria); AstraZeneca – Consultant (1099 relationship)(Fees); Biogen – Consultant (1099 relationship)(Fees); Boehringer Ingelheim – Consultant (1099 relationship)(Fees); Bristol-Myers Squibb – Consultant (1099 relationship)(Fees); Eli Lilly and Company – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Fees); Novartis – Consultant(Honoraria); Pfizer Inc. – Investigator(Fees); Sanofi/Regeneron – Consultant(Honoraria); UCB – Consultant(Honoraria);
Bruce Elliot Strober, MD, PhD, FAAD
AbbVie – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); Alumis – Consultant(Fees); Amgen – Consultant (1099 relationship)(Fees); Arcutis, Inc. – Consultant(Fees), Speaker(Honoraria); Boehringer Ingelheim – Consultant(Honoraria); Bristol Myers Squibb – Speaker(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees); Connect Biopharma LLC – Stockholder(Other Financial Benefit); CoreEvitas, LLC – Advisory Board(Honoraria), Investigator(Fees); Dermavant Sciences, Inc. – Consultant(Fees), Speaker(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); Janssen Biotech – Speaker(Honoraria); Janssen-Ortho Inc. – Advisory Board(Honoraria), Consultant(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria), Consultant(Honoraria); Meiji Seika Pharma Co., Ltd – Consultant(Fees); Mindera – Stockholder(Other Financial Benefit); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria), Consultant(Honoraria); Oruka Therapeutics – Advisory Board(Honoraria); Pfizer Inc. – Consultant(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); UCB – Advisory Board(Honoraria), Consultant(Fees), Speaker(Honoraria); Union Therapeutics – Consultant(Fees);